| SU 11274 |
N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺 |
658084-23-2 |
| BAY 61-3606 (dihydrochloride) |
BAY 61-3606 |
648903-57-5 |
| Inotuzumab ozogamicin |
奥英妥珠单抗 |
635715-01-4 |
| LY-404039 |
(1R,4S,5S,6S)-4-氨基-2-硫杂双环[3.1.0]己烷-4,6-二甲酸 2,2-二氧化物 |
635318-11-5 |
| LORCASERIN |
氯卡色林 |
616202-92-7 |
| 3-[[(tert-Butoxy)carbonyl]amino]-5-fluoro-4-oxopentanoic acid methyl ester |
3-[[叔丁氧羰基]氨基]-5-氟-4-氧代戊酸甲酯 |
634911-80-1 |
| LY2140023 hydrochloride |
化合物POMAGLUMETAD METHIONIL盐酸盐 |
635318-26-2 |
| LY 2140023 |
LY2140023 |
635318-55-7 |
| BMS 564929 |
BMS 564929 |
627530-84-1 |
| Tasimelteon |
他司美琼 |
609799-22-6 |
| MK-0812 |
1,5-酐-2,3-双脱氧-3-[[(1R,3S)-3-[[7,8-二氢-3-(三氟甲基)-1,6-萘啶-6(5H)-基]羰基]-3-(1-甲基乙基)环己基]氨基]-4-O-甲基-D-赤式-戊糖醇 |
624733-88-6 |
| SB-743291 |
SB-743921 |
618430-39-0 |
| AKTI-1/2 |
1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮 |
612847-09-3 |
| MK-0822 |
(2S)-N-(1-氰基环丙基)-4-氟-4-甲基-2-[[(1S)-2,2,2-三氟-1-[4'-(甲基磺酰基)[1,1'-联苯]-4-基]乙基]氨基]戊酰胺 |
603139-19-1 |
| Nedocromil |
尼多克罗 |
69049-73-6 |
| 4-Amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one |
4-氨基-1-[(2R,3S,4R,5R)-3-氟-4-羟基-5-(羟甲基)氧杂环戊-2-基]-5-碘嘧啶-2-酮 |
69123-90-6 |
| BUSERELIN |
醋酸布舍瑞林 |
68630-75-1 |
| Vanoxerine |
VANOXERINE |
67469-69-6 |
| Vanoxerine dihydrochloride |
伐诺司林二盐酸盐 |
67469-78-7 |
| Methasulfocarb |
磺菌威 |
66952-49-6 |
QQ
